Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Investor Relations

Events

B. Riley Securities' 3rd Annual Oncology Conference
 January 18, 2023
 1:30pm - 2:00pm EST

Cardiff Oncology management will participate in a firesidie chat at the B. Riley Securities' 3rd Annual Oncology Conference, which is taking place virtually on January 18-19, 2023.

Details of the CRDF fireside chat are provided below along with a link to register.

January 18th, 2023 - 1:30 pm ET